Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.3400 (3.71%) ($28.0000 - $29.5400) on Tue. Jul. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.75% (three month average) | RSI | 41 | Latest Price | $29.3400(3.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -1.875% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.875% (StdDev 3.75%) | Hourly BBV | 0 () | Intraday Trend | 4% | | | |
|
5 Day Moving Average | $29.53(-0.64%) | 10 Day Moving Average | $29.25(0.31%) | 20 Day Moving Average | $29.19(0.51%) | To recent high | -28.4% | To recent low | 7.8% | Market Cap | $4.296b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |